OECD Science, Technology and Industry Outlook 2010
Hide / Show Abstract

OECD Science, Technology and Industry Outlook 2010

In the search for a rapid, sustainable and lasting recovery from the economic crisis, science, technology and innovation are expected to play a driving role. But what are the implications for science and innovation policy? What steps are countries taking to boost their capabilities in these areas? What place are emerging economies likely to occupy in the science, technology and innovation landscape?

The OECD Science, Technology and Industry Outlook 2010 reviews key trends in science, technology and innovation in OECD countries and a number of major emerging economies including Brazil, China, India, Russia and South Africa. Using the latest available data and indicators, it examines topics high on the agenda of economic policy makers, including performance in science and innovation, trends in national science, technology and innovation policies and the design and assessment of innovation policy, including policy interactions and the "policy mix". It provides individual profiles of the science and innovation performance of each country and relates these to their national context and current policy challenges.

"a comprehensive, up-to-date and authoritative source for graduate students, researchers, and the general public.  Recommended."                                      -Choice

Click to Access: 
Publication Date :
14 Dec 2010
DOI :
10.1787/sti_outlook-2010-en
 
Chapter
 

Denmark You do not have access to this content

Click to Access: 
Author(s):
OECD
Pages :
170–171
DOI :
10.1787/sti_outlook-2010-15-en

Hide / Show Abstract

Denmark is one of the stronger OECD members on a number of science and innovation indicators. It has a modern open market economy featuring a hightechnology agricultural sector and a sophisticated manufacturing industry, with world leaders in pharmaceuticals, maritime shipping and renewable energy. It has a large government R&D budget and high expenditure on biotechnology and pharmaceutical R&D. In 2008, Denmark’s gross domestic expenditure on R&D (GERD) was 2.7% of GDP, firmly above the OECD average of 2.3%. Industry-financed GERD increased to 61%, while government-funded GERD declined to 25%. Business expenditure on R&D (BERD) was a comparatively high 1.9% of GDP in 2008; as a percentage of industry value added, this was almost double the OECD average. In that year, Denmark also had a high venture capital intensity of 0.16%, well above the average.
Also available in: French, German